Efficacy of a Single Preoperative Administration of Action Observation Therapy Associated With Motor Imagery in Patients Undergoing Total Hip Arthroplasty.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Milano
-
Rozzano, Milano, Italy, 20089
- Istituto Clinico Humanitas
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion criteria:
- Total hip arthroplasty (THA) monolateral, first implant
- Locomotor autonomy with or without aids before surgery
- BMI (regular, overweight, Grade I obesity)
- No complications in surgery
- Orthopaedic prescription of tolerance load on the limb
- Autonomy with aids within the third post-operative day
Exclusion Criteria:
- Previous total hip replacement on contralateral hip
- Dementia or other conditions affecting patient's collaboration
- Unresolved clinical complications in the first two post-operative days
- Neurological, musculoskeletal or other disorders able to impact on functional recovery
- Visual or auditory deficits
- Total or partial revisions of THA
- Patients assigned to different groups hospitalized in the same room
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: AOT+MI
participants who, in addiction to standard rehabilitation program after surgery, underwent a single pre-operative training session of action observation therapy associated with motor imagery.
|
Subject is asked to observe videos with motor contents
mental simulation of a motor task
|
|
No Intervention: Control group
Participants who was not subjected to any pre-operative activity.
They received standard rehabilitation program after surgery too.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in functional mobility using Timed Up and Go test (TUG).
Time Frame: Both groups will be evaluated the day before (T0) and 4 days after (T1) surgery.
|
The primary outcome is to investigate whether a single administration consisting of two sessions of AOT and MI performed the day before the total hip arthroplasty may impact on functional recovery in the immediate post-operative period.
Functional mobility will be evaluated with Timed Up and Go test.
|
Both groups will be evaluated the day before (T0) and 4 days after (T1) surgery.
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in maximum gait speed
Time Frame: Both groups will be evaluated the day before (T0) and 4 days after (T1) surgery.
|
Changes in maximum gait speed between and within groups will be evaluated with 10 meters-walking test (10 MWT).
|
Both groups will be evaluated the day before (T0) and 4 days after (T1) surgery.
|
|
Changes in pain using Visual Analogue Scale (VAS)
Time Frame: Both groups will be evaluated the day before (T0) and 4 days after (T1) surgery.
|
Pain will be assessed with Visual Analogue Scale (VAS 0-10) ranging from 0 (absence of pain) to 10 (maximum pain)
|
Both groups will be evaluated the day before (T0) and 4 days after (T1) surgery.
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 750
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.